The appearance of the fundus of the eye varies among the families of osteoglossomorph teleosts. In this study, four different fundal patterns were observed: (i) an anteroposterior (or horizontal) embryonic fissure with a septal falciform process (family Osteoglossidae); (ii) an embryonic fissure from the optic disc nasoventrally with a falciform process (family Arapaimidae); (iii) an embryonic fissure nasoventrally from the optic disc without a falciform process (family Hiodontidae); and (iv) neither an embryonic fissure nor a falciform process (families Notopteridae and Mormyridae). The distribution of these various forms among the osteoglossomorph fishes is consistent with the recent cladogram for the Osteoglossomorpha [Lauder and Liem, 1983] which was based on many characters. The embryonic fissure in adult Amia calva was also examined. Its existence in adult Amia, in most Osteoglossomorpha, and in many non-euteleostean bony fishes suggests that its persistence in the adult stage is a primitive trait of bony fishes, and its absence in the Notopteroidei (with the exception of Hiodon) is a derived condition.

Keywords:
Eye, Embryonic fissure, Falciform process, Osteoglossomorpha, Evolution
This content is only available via PDF.
© 1985 S. Karger AG, Basel
1985
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.